Cargando…
Discriminating between competing models for the allosteric regulation of oncogenic phosphatase SHP2 by characterizing its active state
The Src-homology 2 domain containing phosphatase 2 (SHP2) plays a critical role in crucial signaling pathways and is involved in oncogenesis and in developmental disorders. Its structure includes two SH2 domains (N-SH2 and C-SH2), and a protein tyrosine phosphatase (PTP) domain. Under basal conditio...
Autores principales: | Calligari, Paolo, Santucci, Valerio, Stella, Lorenzo, Bocchinfuso, Gianfranco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Research Network of Computational and Structural Biotechnology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8632847/ https://www.ncbi.nlm.nih.gov/pubmed/34900129 http://dx.doi.org/10.1016/j.csbj.2021.10.041 |
Ejemplares similares
-
Structural Determinants of Phosphopeptide Binding
to the N-Terminal Src Homology 2 Domain of the SHP2 Phosphatase
por: Anselmi, Massimiliano, et al.
Publicado: (2020) -
Targeting Oncogenic
Src Homology 2 Domain-Containing
Phosphatase 2 (SHP2) by Inhibiting Its Protein–Protein Interactions
por: Bobone, Sara, et al.
Publicado: (2021) -
Targeting a Cryptic Allosteric Site for Selective
Inhibition of the Oncogenic Protein Tyrosine Phosphatase Shp2
por: Chio, Cynthia M., et al.
Publicado: (2014) -
Therapeutic Potential of Targeting
the Oncogenic SHP2
Phosphatase
por: Zeng, Li-Fan, et al.
Publicado: (2014) -
Mechanism of activating mutations and allosteric drug inhibition of the phosphatase SHP2
por: Pádua, Ricardo A. P., et al.
Publicado: (2018)